Table 5 Safety profile of the participants (Mothers) in both the study groups

Haemoglobin (g/dl)

Baseline

11.78 ± 1.536

11.61 ± 1.363

90th day

11.88 ± 1.226

11.99 ± 1.303

p-value^#

0.602

0.040 (*)

Liver Function Test (LFT)

Total billirubin (mg/dl)

Baseline

0.59 ± 0.284

0.66 ± 0.341

90th day

0.63 ± 0.345

0.61 ± 0.301

p-value^#

0.575

0.287

AST (IU/L)

Baseline

41.84 ± 20.876

36.12 ± 15.277

90th day

39.00 ± 20.880

31.69 ± 15.261

p-value^#

0.317

0.035 (*)

ALT (IU/L)

Baseline

52.11 ± 31.734

40.84 ± 18.578

90th day

47.40 ± 37.812

38.80 ± 20.822

p-value^#

0.289

0.398

S.Alkaline Phosphatase (U/L)

Baseline

131.77 ± 55.980

123.95 ± 59.998

90th day

118.07 ± 42.907

118.80 ± 51.852

p-value^#

0.009 (*)

0.240

Renal Function Test (RFT)

Blood Urea (mg/dl)

Baseline

24.38 ± 8.519

23.25 ± 6.314

90th day

24.59 ± 7.235

23.24 ± 6.736

p-value^#

0.745

0.988

S.Creatinine (mg/dl)

Baseline

0.75 ± 0.257

0.72 ± 0.167

90th day

0.77 ± 0.184

0.77 ± 0.200

p-value^#

0.579

0.030 (*)